2024 NOSCM | Upfront Treatment for Common Ovarian Cancer (High Grade Serous) Versus Rare Histologies-- Focus on PARPi and Other Targeted Therapies
0% Complete
Course Content
This material is non-CME, no credits are available, and a certificate will not be provided upon completion.
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Faculty & Disclosure
Faculty
Tara Castellano, MD
Disclosure
Tara Castellano, MD discloses no such relationships exist
Accreditation
NA
-1769183671548.webp&w=3840&q=75)
-1769183559393.webp&w=3840&q=75)